Transformation of chicken myelomonocytic cells by a retrovirus expressing the v-myb oncogene from the long terminal repeats of avian myeloblastosis virus but not Rous sarcoma virus
- PMID: 1323701
- PMCID: PMC289093
- DOI: 10.1128/JVI.66.9.5373-5383.1992
Transformation of chicken myelomonocytic cells by a retrovirus expressing the v-myb oncogene from the long terminal repeats of avian myeloblastosis virus but not Rous sarcoma virus
Abstract
To test the effect of long terminal repeat (LTR) regulatory sequences on the transforming capability of the v-myb oncogene from avian myeloblastosis virus (AMV), we have constructed replication-competent avian retroviral vectors with nearly identical structural genes that express v-myb from either AMV or Rous sarcoma virus (RSV) LTRs. After transfection into chicken embryo fibroblasts, virus-containing cell supernatants were used to infect chicken myelomonocytic target cells from preparations of 16-day-old embryonic spleen cells. Both wild-type AMV and the virus expressing v-myb from AMV LTRs (RCAMV-v-myb) were able to transform the splenocyte cultures into a population of immature myelomonocytic cells. The transformed cells expressed the p48v-Myb oncoprotein and formed compact foci when grown in soft agar. In contrast, the virus expressing v-myb from RSV LTRs (RCAS-v-myb) was repeatedly unable to transform the same splenocyte cells, despite being able to infect fibroblasts with high efficiency. This difference in the transforming activities of v-myb-expressing viruses with different LTRs most likely results from the presence of a factor (or factors) within the appropriate myelomonocytic target cell that promotes specific expression from the AMV but not from the RSV LTR.
Similar articles
-
Transformation of myelomonocytic cells by the avian myeloblastosis virus is determined by the v-myb oncogene, not by the unique long terminal repeats of the virus.J Virol. 1994 Apr;68(4):2752-5. doi: 10.1128/JVI.68.4.2752-2755.1994. J Virol. 1994. PMID: 8139052 Free PMC article.
-
Effects of 5' and 3' truncations of the myb gene on the transforming ability of avian myeloblastosis virus (AMV).Virology. 1990 Apr;175(2):562-7. doi: 10.1016/0042-6822(90)90441-s. Virology. 1990. PMID: 2158185
-
Transformation by v-Myb.Oncogene. 1999 May 13;18(19):3047-55. doi: 10.1038/sj.onc.1202745. Oncogene. 1999. PMID: 10378700 Review.
-
tom-1, a novel v-Myb target gene expressed in AMV- and E26-transformed myelomonocytic cells.EMBO J. 1997 Mar 17;16(6):1371-80. doi: 10.1093/emboj/16.6.1371. EMBO J. 1997. PMID: 9135152 Free PMC article.
-
The myb oncogene.Gene Amplif Anal. 1986;4:73-98. Gene Amplif Anal. 1986. PMID: 3333362 Review.
Cited by
-
Alterations of the MDV oncogenic regions in an MDV transformed lymphoblastoid cell line.Mol Pathol. 2002 Aug;55(4):262-72. doi: 10.1136/mp.55.4.262. Mol Pathol. 2002. PMID: 12147717 Free PMC article.
-
Minimal truncation of the c-myb gene product in rapid-onset B-cell lymphoma.J Virol. 1997 Sep;71(9):6526-33. doi: 10.1128/JVI.71.9.6526-6533.1997. J Virol. 1997. PMID: 9261372 Free PMC article.
-
Transformation of myelomonocytic cells by the avian myeloblastosis virus is determined by the v-myb oncogene, not by the unique long terminal repeats of the virus.J Virol. 1994 Apr;68(4):2752-5. doi: 10.1128/JVI.68.4.2752-2755.1994. J Virol. 1994. PMID: 8139052 Free PMC article.
-
Overexpression of C-terminally but not N-terminally truncated Myb induces fibrosarcomas: a novel nonhematopoietic target cell for the myb oncogene.Mol Cell Biol. 1994 Apr;14(4):2278-90. doi: 10.1128/mcb.14.4.2278-2290.1994. Mol Cell Biol. 1994. PMID: 8139533 Free PMC article.
-
Vectors derived from avian leukosis and sarcoma viruses.J Mol Med (Berl). 1995 Apr;73(4):181-7. doi: 10.1007/BF00188138. J Mol Med (Berl). 1995. PMID: 7627638 Review. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources